BioNTech SE

BioNTech SEverified

BNTX

Price:

$108.97

Market Cap:

$23.81B

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, a preclinical stage product for non-small cell lung cancer. It also develops neoantigen specific immunotherapies, such as Autogene cevumeran (BNT122),...[Read more]

Industry

Biotechnology

IPO Date

2019-10-10

Stock Exchange

NASDAQ

Ticker

BNTX

The Enterprise Value as of November 2024 (TTM) for BioNTech SE (BNTX) is 13.69B

According to BioNTech SE’s latest financial reports and current stock price. The company's current Enterprise Value is 13.69B. This represents a change of 30.29% compared to the average of 10.50B of the last 4 quarters.

BioNTech SE (BNTX) Historical Enterprise Value (quarterly & annually)

How has BNTX Enterprise Value performed in the past?

The mean historical Enterprise Value of BioNTech SE over the last ten years is 13.92B. The current 13.69B Enterprise Value has changed 9.73% with respect to the historical average. Over the past ten years (40 quarters), BNTX's Enterprise Value was at its highest in in the September 2021 quarter at 55.50B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.

Quarterly (TTM)
Annual

Average

13.92B

Median

8.73B

Minimum

-277011000.00

Maximum

53.93B

BioNTech SE (BNTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BioNTech SE Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 266.00%

Maximum Annual Enterprise Value = 53.93B

Minimum Annual Increase = -1027.48%

Minimum Annual Enterprise Value = -277011000.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202311.53B-43.68%
202220.47B-62.04%
202153.93B266.00%
202014.73B148.07%
20195.94B141.46%
20182.46B-4.26%
20172.57B-1027.48%

BioNTech SE (BNTX) Average Enterprise Value

How has BNTX Enterprise Value performed in the past?

The current Enterprise Value of BioNTech SE (BNTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

28.64B

5-year avg

21.32B

10-year avg

13.92B

BioNTech SE (BNTX) Enterprise Value vs. Peers

How is BNTX’s Enterprise Value compared to its peers?

BioNTech SE’s Enterprise Value is greater than Novavax, Inc. (1.00B), greater than CohBar, Inc. (-4506335.00), greater than Ginkgo Bioworks Holdings, Inc. (143.59M), greater than CRISPR Therapeutics AG (4.06B), less than Ocean Biomedical, Inc. (0), greater than Enveric Biosciences, Inc. (42.20M), greater than Hepion Pharmaceuticals, Inc. (636.29K), greater than Elevation Oncology, Inc. (1.72M), greater than AVROBIO, Inc. (2.36M), greater than PTC Therapeutics, Inc. (-85302404.00), greater than Krystal Biotech, Inc. (2.85B), greater than Sarepta Therapeutics, Inc. (4.54B), greater than Iovance Biotherapeutics, Inc. (12.72B), greater than Madrigal Pharmaceuticals, Inc. (3.33B), greater than null (6.99B),

Build a custom stock screener for BioNTech SE (BNTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioNTech SE using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioNTech SE (BNTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioNTech SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is BioNTech SE's Enterprise Value?

What is the highest Enterprise Value for BioNTech SE (BNTX)?

What is the 3-year average Enterprise Value for BioNTech SE (BNTX)?

What is the 5-year average Enterprise Value for BioNTech SE (BNTX)?

How does the current Enterprise Value for BioNTech SE (BNTX) compare to its historical average?